Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
DiProServa Medical AB
AB
Active
Org 5566996178
Adelgatan 21, 211 22
Malmö
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2006 · 20 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
DiProServa Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
25M
19M
12M
6M
0M
2020: 12M
12M
2020
2021: 16M (+33% vs 2020)
16M
+33%
2021
2022: 18M (+13% vs 2021)
18M
+13%
2022
2023: 19M (+6% vs 2022)
19M
+6%
2023
2024: 20M (+5% vs 2023)
20M
+5%
2024
EBITDA
SEK millions
17M
13M
9M
4M
0M
2020: 8M
8M
2020
2021: 11M (+38% vs 2020)
11M
+38%
2021
2022: 12M (+9% vs 2021)
12M
+9%
2022
2023: 12M (0% vs 2022)
12M
0%
2023
2024: 14M (+17% vs 2023)
14M
+17%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
19 938
19 096
17 757
16 190
12 229
Staff expenses
—
—
—
—
—
EBITDA
13 674
12 349
12 121
11 110
8 309
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
13 674
12 349
12 121
11 110
8 309
Net financials
−2
−1
−21
−70
−92
Profit before tax
11 619
9 803
6 930
0
6 155
Tax
−2 478
−2 064
−1 451
−9
−1 324
Net profit
9 141
7 739
5 479
−9
4 831
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
82 752
63 375
45 255
32 250
24 629
Equity
34 823
25 681
17 942
12 463
12 472
Long-term debt
0
0
0
0
0
Short-term debt
34 970
26 788
18 953
12 596
4 866
Total debt
34 970
26 788
18 953
12 596
4 866
Financial ratios
5-year trend
EBITDA margin
68,6 %
This company
15,8 %
Market median
This company
Market median
334% above market
2020
2024
Equity ratio
42,1 %
This company
38,2 %
Market median
This company
Market median
10% above market
2020
2024
Return on equity
26,2 %
This company
18,4 %
Market median
This company
Market median
42% above market
2020
2024
Net profit margin
45,8 %
This company
8,1 %
Market median
This company
Market median
465% above market
2020
2024
Asset turnover
0,24×
This company
1,12×
Market median
This company
Market median
79% below market
2020
2024
Debt / equity
1,38×
This company
0,62×
Market median
This company
Market median
123% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on DiProServa Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
